Diacylglycerol (DG) kinase (DGK) phosphorylates the lipid second messenger DG to phosphatidic acid. We reported previously that noradrenaline (NA), but not angiotensin II (AII), increases membrane-associated DGK activity in rat small arteries [Ohanian and Heagerty (1994) Biochem. J. 300, 51-56]. Here, we have identified this DGK activity as DGKθ, present in both smooth muscle and endothelial cells of these small vessels. Subcellular fractionation of artery homogenates revealed that DGKθ was present in nuclear, plasma membrane (and\or Golgi) and cytosolic fractions. Upon NA stimulation, DGKθ translocated towards the membrane and cytosol (155 and 153 % increases relative to the control, respectively) at 30 s, followed by a return to near-basal levels at 5 min ; AII was without effect. Translocation to the membrane was to both Triton-soluble and
INTRODUCTION
Diacylglycerol kinase (DGK ; EC 2.7.1.107) phosphorylates 1,2-diacylglycerol (DG) to phosphatidic acid (PA) [1] and plays an important role in signal transduction mediated by inositol phospholipid turnover [2, 3] . In vascular smooth muscle, hormones such as noradrenaline (NA) and angiotensin II (AII) initiate contraction by activating phospholipase C. Hydrolysis of the membrane lipid PtdIns(4,5)P # by activated phospholipase C produces two second messengers, DG and Ins(1,4,5)P $ [4] . Whereas Ins(1,4,5)P $ mobilizes intracellular Ca# + leading to smooth-muscle contraction [5] , DG is thought to increase contractile force and regulate cell growth and proliferation through its ability to activate protein kinase C (PKC) [6, 7] . In contrast, conversion of DG into PA by DGK will act to attenuate PKC activity [8, 9] .
To date, nine mammalian DGK isoforms have been identified which differ in their activators, substrate specificity, tissue expression and structural domains (reviewed in [3] ) [10, 11] . For example, while cysteine-rich domains are common to all known DGKs, only type-I DGKs (α, β and γ) possess EF-hand motifs that bind to, and are activated by, calcium. Type-II DGKs (δ and η) have N-terminal pleckstrin homology (PH) domains but lack EF-hands. Type-I, -III (ε), -IV (ζ) and -V (θ) DGKs are all activated by phosphatidylserine and only the type-III isoform (ε)
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-insoluble fractions. NA, but not AII, transiently increased DGKθ activity in immunoprecipitates (126 % at 60 s). Membrane translocation and DGKθ activation were regulated differently : NA-induced DGKθ activation, but not translocation, was dependent on transient activation of phosphoinositide 3-kinase (PI 3-K). In addition, DGK activity co-immunoprecipitated with protein kinase B, a downstream effector of PI 3-K, and was increased greatly by NA stimulation. The rapid and agonistspecific activation of DGKθ suggests that this pathway may have a physiological role in vascular smooth-muscle responses.
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shows clear substrate specificity-preference for arachidonate in the sn-2 position of the glycerol backbone. Furthermore, whereas DGKη possesses a broad tissue distribution, the other isoforms do not. DGKθ is structurally different from other characterized DGK isoforms and contains unique features such as three (instead of two) cysteine-rich domains, a proline-and glycinerich region and a Ras-associating domain located within a PH domain [12] . Recently, active RhoA was shown to bind to and inactivate DGKθ [13] , suggesting that agonists which signal through Rho (e.g. G-protein-coupled-receptor agonists) could regulate the activity of this isoform. While very little is known about the role and regulation of DGK isoforms in signal transduction, their different properties and tissue distribution strongly suggest their involvement in different cellular functions.
The majority of studies which show that DGKs are regulated following cell stimulation have used whole extracts in which multiple isoforms are present [14] [15] [16] [17] [18] and, to date, studies on stimulus-induced translocation and activation of specific DGK isoforms are scarce and have been restricted to DGKα and ζ [3] . Phosphoinositide 3-kinases (PI 3-Ks) are a large family of intracellular signal transducers implicated in the regulation of cell proliferation, survival, metabolism, cytoskeletal reorganization and membrane trafficking [19] . PI 3-Ks phosphorylate phosphoinositols in the D-3 position of the inositol ring producing 3-phosphoinositides, now recognized as import-ant second messengers [19] . These phospholipids can interact with the PH domains of protein kinases regulating their subcellular localization and\or activity [19, 20] . An established target of PI 3-K activation is the serine-threonine kinase Akt\protein kinase B (PKB), thought to play a role in protecting cells from apoptosis and promoting cell survival [21] . Whereas Akt\PKB binds 3-phosphoinositides at its PH domain, localizing the kinase to the plasma membrane [21] , phosphorylation on threonine$!) and serine%($ by phosphatidylinositol-dependant kinases (PDK1 and PDK2) is required for activation [21] . Recently, G-protein-coupled-receptor agonists have been shown to activate Akt\PKB by both PI 3-K-dependent and -independent mechanisms in many cell types [22, 23] , including vascular smooth-muscle cells [24] . However, the consequences of such activation and targets of Akt\PKB in response to G-proteincoupled receptors are unclear.
Previously, using an intact vascular smooth-muscle preparation, rat small arteries, we have shown that agonists such as NA and AII acting through G-protein-coupled receptors stimulate phospholipase C, which hydrolyses PtdIns(4,5)P # , resulting in a rapid and transient increase in Ins(1,4,5)P $ [4, 25] . However, the profile of lipid second messengers differed between agonists such that phosphoinositide-derived DG was increased by AII but unchanged by NA [26, 27] . In contrast, phosphoinositide-derived PA accumulated with time in NA-stimulated arteries but was only slightly and transiently increased by AII, suggesting regulation by DGK. Indeed, further studies demonstrated that NA stimulation rapidly and transiently increased membraneassociated DGK activity in small arteries, whereas AII did not [28] . Here we report the identification of DGKθ [12, 13] in these arteries and present evidence that this isoenzyme both translocates to the plasma membrane and is activated following stimulation with NA but not AII. In addition, we demonstrate that NA-induced activation but not membrane association of DGKθ is dependent on activation of a PI 3-K pathway. We show that this isoform is therefore at least partly responsible for regulating DG and PA levels during agonist stimulation in rat small mesenteric arteries.
EXPERIMENTAL Materials
Tissue-culture medium (M199) was from Gibco (Paisley, Scotland, U.K.). Silica-gel 60 TLC plates and HPLC-grade solvents were from British Drug Houses (Poole, Dorset, U.K.), whereas [γ-$#P]ATP (specific radioactivity 370 MBq:ml V ") was from Amersham International (Amersham, Bucks, U.K.). Protein A-agarose and Protein G-plus-agarose beads, wortmannin and LY294002 [2-(4-morpholinyl)-8-phenyl-H-1-bezopyran-4-one] were purchased from Calbiochem-Novabiochem (Nottingham, U.K.), Protogel [30 % (w\v) acrylamide] was from National Diagnostics (Hull, N. Yorks., U.K.), MSI NitroPlus nitrocellulose membrane was from Genetics Research Instrumentation (Braintree, Essex, U.K.) and enhanced chemiluminescence (ECL) kits were from Pierce and Warriner (Chester, U.K.). Cy2 and Cy3 secondary antibodies were from Jackson Immunochemicals (West Grove, PA, U.S.A.). Anti-Akt1\PKB antibody was from UBI (Lake Placid, NY, U.S.A.) and antiAkt\PKB[pS%($] phosphospecific antibody was from QCB (Hopkinton, MA, U.S.A.). Monoclonal anti-DGKθ was from Transduction Laboratories (Lexington, KY, U.S.A.). Antibodies against α-smooth-muscle actin (clone IA4) and von Willebrand factor, 1,2-dioleoyl-glycerol, noradrenaline hydrochloride, AII, octyl-β-glucoside (OBG) and all other chemicals were purchased from Sigma (Poole, Dorset, U.K.). ]. An aliquot was removed from each sample for protein determination using the method of Bradford [29] and the protein amounts in each sample equalized before subcellular fractionation or immunoprecipitation, as described below.
Agonist treatment and preparation of small-artery homogenates

Subcellular fractionation of small-artery homogenates
Differential centrifugation was used to identify the cellular component(s) with which DGKθ was associated. Tissue homogenate was centrifuged at 800 g in a Beckman TL100 ultracentrifuge for 10 min at 4 mC to obtain the low-speed pellet which contained nuclei and unhomogenized tissue. The supernatant was then centrifuged at 10 000 g to collect the heavy membrane pellet containing most of the mitochondrial and lysosomal membranes. That supernatant was re-centrifuged at 150 000 g to yield the light (plasma) membrane pellet and final cytoplasmic supernatant [30] . Each pellet was washed twice with homogenization buffer to remove residual cytosolic proteins. The Triton X-100-insoluble fraction was prepared by resuspending the light membrane pellet in homogenization buffer containing 1 % (w\v) Triton X-100 and mixing for 30 min at 4 mC. These samples were then centrifuged again at 150 000 g to separate the solubilized proteins from the non-solubilized material. All fractions were boiled for 5 min in Laemmli sample buffer [31] and either used immediately or stored frozen at k20 mC.
Microscopic analysis of the low-speed pellet indicated that it contained nuclei and unhomogenized tissue (results not shown). Therefore nuclei were purified further by centrifuging the crude nuclear fraction through three layers of muslin at low speed in a bench-top microfuge to remove tissue debris, followed by sucrose density centrifugation. An aliquot of the centrifuged filtrate was laid over a 2.0 M sucrose cushion and centrifuged at 150 000 g for 90 min to remove adherent organelle structures from the nuclei [30, 32] .
For enzymic (marker) analysis of fractions phosphatase inhibitors were excluded from the homogenization buffer. Alkaline phosphatase (plasma membrane) was assayed in 25 mM sodium borate, pH 9.8\2 mM MgCl # with 8 mM p-nitrophenyl phosphate as substrate ; succinate dehydrogenase (mitochondria) and lactate dehydrogenase (cytosol) were assayed as detailed by Pennington [33] and Storey and Madden [34] , respectively. DNA, detected on agarose gels following ethidium bromide staining, was used as a marker for nuclei [30] .
SDS/PAGE and Western analysis
SDS\PAGE was carried out on discontinuous vertical slab gels [31] containing 10 % (v\v) acrylamide in the resolving gel. Proteins were transferred to nitrocellulose membranes [35] using a semi-dry transfer unit and the membranes blocked for 1 h with 5 % (w\v) non-fat dried milk in 0.1 % Tween\Tris-buffered saline. Membranes were then incubated for 1 h with anti-DGKθ polyclonal antibody 101 (1\1000 dilution), raised against a synthetic peptide corresponding to the stretch of amino acids 312-331 in the DGKθ primary sequence [13] . Signals were developed by incubating the membrane with horseradish peroxidase-conjugated secondary antibody for 45 min followed by detection with an enhanced chemiluminescence kit. Bands corresponding to DGKθ were analysed using densitometry (BioRad imaging densitometer), and the band intensities measured using Molecular Analyst Software. Signal specificity was demonstrated by competing off polyclonal antibody 101 with the immunizing peptide. For detection of Akt\PKB phosphorylation, membranes were incubated overnight with phosphospecific anti-Akt\PKB[pS%($] antibody that recognizes Akt\PKB only when phosphorylated on serine%($. Following signal development the membranes were stripped by incubation in 62.5 mM Tris\ HCl, pH 6.8, 100 mM 2-mercaptoethanol and 2 % SDS for 45 min at 80 mC, washed in 0.1 % Tween\Tris-buffered saline and reprobed with anti-Akt\PKB antibody. Band intensities were measured using densitometry and the phospho-Akt\PKB signal was corrected for total Akt\PKB. Phosphorylation of Akt\PKB on serine%($ is required for activation [21] ; therefore phosphorylation at this site was taken as a measure of activation.
Immunoprecipitations
DGKθ was immunoprecipitated under native conditions. Following stimulation with NA or AII, as described above, vessels were homogenized and the homogenate clarified by brief centrifugation (10 s) in a bench-top microfuge. Equal amounts of artery homogenate protein [in 150 µl of homogenization buffer containing 1 % (w\v) fatty acid-free BSA] were incubated for 3 h at 4 mC with 7.5 µl of anti-DGKθ polyclonal antibody 104 (raised against purified glutathione S-transferase-DGKθ fusion protein). To overcome non-specific binding of DGKθ to Protein-A beads, immunocomplexes were collected with pre-blocked (1 % fatty acid free BSA) Protein A-agarose beads for 3 min at 4 mC, conditions which still allow for efficient immunocomplex adsorption [36] . Immunoprecipitates were washed three times with 800 µl of homogenization buffer and proteins were extracted with 2 i Laemmli sample buffer for Western blotting or resuspended in DGK assay buffer (below) for measurement of DGKθ activity. Immunoprecipitates were also prepared from cytosolic fractions for measurement of cytosolic DGKθ activity. The same conditions were used for immunoprecipitation of Akt\PKB except that 5 µg of anti-Akt\PKB antibody was used and immunocomplexes were collected with pre-blocked (1 % fatty acid-free BSA) Protein G-plus-agarose beads.
Assay of DGK activity
The OBG mixed-micelle assay [37] was used to determine DGK activity in immunoprecipitates. Briefly, a mixed-micelle solution was prepared from a lipid suspension [12 mM 1,2-dioleoylglycerol and 23.2 mM phosphatidylserine (from 10 mg ml V " stocks in chloroform) in 400 mM OBG] by sonication for 30 s in a bath-type sonicator and frequent vortex mixing. The reaction mixture (final volume 80 µl) contained the resuspended immunoprecipitate, DGK assay buffer (final concentrations, 50 mM Tris\HCl, pH 7.4, 10 mM NaF, 10 mM MgCl # and 1 mM dithiothreitol), 10 µl of mixed-micelle solution and 10 µl of [$#P]ATP (1.25 mM ATP, 100-200 d.p.m.\pmol) to start the reaction. After incubation for 10 min at 30 mC, the reaction was stopped by adding 300 µl of chloroform\methanol\10 M HCl (66 : 33 : 1, by vol.) and washed with 250 µl of pure upper phase (chloroform\methanol\water, 3 : 48 : 47, by vol.). The resultant organic phase was dried under O # -free N # gas, reconstituted in 25 µl of chloroform and spotted on to heat-activated silica-gel 60 TLC plates. The plates were developed in chloroform\acetone\ methanol\acetic acid\water (10 : 4 : 3 : 2 : 1, by vol.) and [$#P]PA counted directly using an Instant Imager (Canberra Packard). DGK activity was measured in lysates from COS cells transfected with cDNA of human DGKθ or the empty pmtSM vector as described in [12] .
Immunohistochemistry
Arteries dissected for immunohistochemistry were fixed in 4 % (w\v) paraformaldehyde for 30 min at room temperature and washed five times with PBS. They were then cryoprotected by infusion for a minimum of 2 h with a polyvinyl pyrrolidone\ sucrose mixture [38] , mounted on aluminium cryopins and plunge-frozen in liquid nitrogen. Semi-thin cryosections (0.2-0.5 µm thick) were prepared using a Reichert-Jung cryoultramicrotome in combination with glass knives [39] . Sections were retrieved on droplets of 2 M sucrose plus 0.75 % gelatin, transferred to 4 mm glass coverslips coated with 0.1 % (w\v) poly--lysine, and stored in Tris buffer (20 mM Tris\HCl, pH 7.6\155 mM NaCl\2 mM MgCl # \2 mM EGTA) at 4 mC before immunolabelling. Sections were single-labelled with anti-DGKθ monoclonal antibody (1\50 dilution), or were doublelabelled with primary antibodies against von Willebrand factor (polyclonal, 1\1500 dilution) and α-smooth-muscle actin (monoclonal, 1\1000 dilution) before labelling with Cy2-conjugated goat anti-rabbit and Cy3-conjugated anti-mouse secondary antibodies (1\1000 dilution). Microscopy was carried out using a Zeiss Axioplan equipped with epifluorescent optics.
Statistical analyses
The results are expressed as meanspS.E.M. or S.D. Where appropriate, data were analysed by analysis of variance (ANOVA) using the statistical software package INSTAT.
RESULTS
Subcellular distribution of DGKθ in resting vessels
Western-blot analysis using anti-DGKθ polyclonal antibody 101 revealed that DGKθ is present in total homogenates from unstimulated rat small mesenteric arteries. Specificity, as seen by the loss of immunoreactive signal, was demonstrated by pre-
Figure 1 Identification and subcellular distribution of DGKθ in intact small arteries
(A) Representative immunoblot showing the presence of DGKθ in total homogenate, crude nuclear and cell-debris, light membrane and cytosol fractions, prepared from artery homogenates as described in the Experimental section. Total artery homogenate (10 µg), 50 % of the crude nuclear and cell-debris (due to high signal intensity) and 100 % of the remaining fractions were resolved by SDS/PAGE and processed for immunoblotting. DGKθ was visualized using polyclonal antibody 101 and ECL detection. The signal was competed off by adding 5 µl of 101 immunizing peptide to 10 ml of primary antibody solution before the primary incubation stage. The immunoblot is representative of 16 similar experiments. (B) DGKθ is present in both purified nuclei and adherent membranes. The nuclear and cell-debris fraction was filtered to produce a crude nuclear fraction which was purified further into nuclei and adherent membranes by sucrose-density centrifugation as described in the Experimental section. These fractions were then immunoblotted and probed with polyclonal antibody 101. Results are representative of three independent experiments. (C) DGKθ is present in both detergent-insoluble and -soluble fractions. Plasma-membrane fractions were prepared as described in the Experimental section and were then solubilized with 1 % Triton X-100. The immunoblot is representative of two independent experiments. incubating 101 antibody with the immunizing peptide before the primary-antibody incubation stage ( Figure 1A) . The apparent molecular mass of DGKθ in small arteries was similar to that reported for the purified protein (M r 110 000) [40] , and is close to its calculated mass (M r 101 300) [12] .
The subcellular localization of DGKθ was determined by differential centrifugation of vessel homogenates. The composition of the fractions was confirmed by marker-enzyme analysis and DNA quantitation : 93 % of the DNA was found in the crude nuclear and cell-debris fraction, the heavy membrane fraction contained 47 % of the total succinate dehydrogenase (mitochondrial marker) activity, the light membrane fraction contained 67 % of the alkaline phosphatase (plasma membrane) activity and 97 % of the lactate dehydrogenase (cytosol) activity was found in the final supernatant [30, 32] (Table 1) . DGKθ was present in the crude nuclear and cell-debris, light membrane (plasma membrane and Golgi) and supernatant (cytosol) fractions ( Figure 1A) . No DGKθ was detected in the heavy membrane (lysosome and mitochondria) fraction. Further purification of the crude nuclear and cell-debris fraction by filtration and sucrose-density centrifugation showed that DGKθ was present in the nuclei and adherent organelle structures ( Figure 1B ). Many proteins involved in signal transduction have been identified in the membrane-derived, detergent-insoluble fraction, where they interact with membrane lipids to form signalling complexes [41, 42] . It was not possible to completely extract DGKθ from the light membranes using Triton X-100, demonstrating that DGKθ is partly associated with this fraction ( Figure 1C ).
Immunohistochemistry
Immunohistochemistry was done on thin transverse sections of small arteries to determine the cellular distribution of DGKθ within the vessel wall. Single-labelling with monoclonal anti-DGKθ and double-labelling with antibodies against von Willebrand factor (endothelial-cell marker) and α-smooth-muscle actin (smooth-muscle-cell marker) revealed that DGKθ is expressed in both the vascular smooth-muscle cells and the endothelial cells of rat small mesenteric arteries (Figure 2) .
Effect of agonists on the subcellular distribution of DGKθ
The effect of two vasoconstrictor hormones, NA and AII, on the subcellular localization of DGKθ in small mesenteric arteries was investigated. These agonists were chosen since they both induce an immediate increase in Ins(1,4,5)P $ [25] , but their effects on DG and PA accumulation differ such that DG accumulates following AII stimulation whereas PA accumulates with NA [26] .
Stimulation of intact small arteries with 15 µM NA induced a transient increase in the amount of DGKθ present in both the light membrane and cytosolic fractions. This response was rapid and transient, with a 2.5-fold increase in DGKθ levels at 30 s, returning towards the baseline after 5 min of stimulation ( Figure  3A) . The NA-induced increase in the amount of DGKθ present in the light membrane fraction was also found to be doseresponsive such that greater translocation of DGKθ was observed with higher agonist concentrations ( Table 2) . A dose-responsive effect of NA on the amount of DGKθ present in the cytosol was
Figure 2 DGKθ is expressed by vascular smooth-muscle and endothelial cells
Immunofluorescence micrographs of thin transverse sections through rat arteries, doublelabelled with antibodies against von Willebrand factor (a) and α-smooth-muscle actin (b) and single-labelled with monoclonal antibody against DGKθ (c). Endothelial cells (e) are delineated by their strong expression of von Willebrand factor (a). They are unreactive with an antibody against α-smooth-muscle actin (b), which exclusively outlines the cytoplasm of smooth-muscle cells belonging to the tunica media (tm), whereas nuclei (arrows) remain unstained. DGKθ (c) is present within smooth-muscle cells and the endothelium. Specificity of the DGKθ signal is demonstrated by the absence of non-specific staining by the secondary antibodies of smooth muscle in (a) and endothelial cells in (b). Scale bar, 50 µm.
Table 2 DGKθ concentration in the light membrane and cytosol fractions as a function of NA concentration
Following a 30 s stimulation with various concentrations of NA, subcellular fractions were immunoblotted using polyclonal antibody 101 and ECL detection. Immunoblots (n l 7) were scanned by densitometry and the data expressed relative to the control (0 s) as meanspS.E.M. *P 0.05 and ***P 0.001, compared with the control values (0 s). less marked, but significantly more enzyme was present in the cytosol following stimulation with 15 µM NA than in the cytosol from control vessels. While we were able to detect increases in the amount of DGKθ present in the light membrane and cytosolic fractions at all time points (30-300 s) and NA doses (0.1-15 µM), we were unable to detect any significant decreases in the amount of DGKθ associated with the crude nuclear and cell debris fraction ( Figure 3A ). This is possibly because the amount of DGKθ in this crude fraction is so high that relatively small effluxes escaped detection. Following stimulation with NA, DGKθ translocated to both the Triton-X-100-soluble and -insoluble light membrane fractions (215p34 % and 136p20 % increase over non-stimulated levels respectively, meanpS.D., n l 2). In contrast to the effect of NA on DGKθ levels, stimulation of intact small arteries with AII (100 nM) did not significantly alter the amount of DGKθ present in either the light membrane or cytosolic fraction ( Figure 3B ). Although there was a degree of variability in membrane and cytosol DGKθ levels following AII stimulation ( Figure 3B ) this most probably reflected the heterogeneity in rat populations and the intact small-artery preparations used. Certainly no large or consistent response was detected. This observation and that of the dose-responsive effect of NA demonstrate the specific effect of NA.
Effect of agonists on the activity of DGKθ
Following agonist stimulation, DGKθ activity was measured after immunoprecipitation using the OBG mixed-micelle assay [37] . This was the preferred choice over the deoxycholate method since OBG mixed micelles provide a single homogeneous phase incorporating enzyme, DG substrate and lipid cofactor. Under these conditions DGK activity is not limited by the delivery of the water-insoluble substrate. In addition, we have shown previously using rat small-artery particulate and cytosolic fractions that this assay selectively measures membraneassociated DGK activity [28] . To confirm that a similar selectivity was shown for DGKθ in the current study, we measured kinase activity in immunoprecipitates prepared from either clarified homogenates or cytosols. Cytosolic DGKθ activity was low in this assay and the majority of activity (71p0.4 %, meanpS.D. of two experiments performed in duplicate) was due to membrane-associated DGKθ.
Stimulation of intact small arteries with 15 µM NA induced a transient increase in DGKθ activity ( Figure 4A ). Similar to the translocation of DGKθ, this response was rapid and short-lived, with the greatest increase in activity following 60 s stimulation and returning towards baseline levels after 300 s. The presence of equivalent amounts of DGKθ in the immunoprecipitates was confirmed by Western blotting ( Figure 4B ). In contrast to NA, stimulation of the arteries with 100 nM AII did not increase the activity of DGKθ at any of the time points studied ( Figure 4A ). Instead, a small but significant decrease in DGKθ activity was seen at 30 s AII stimulation, which is in agreement with our previous data on DGK activity at this time point, particularly in the membrane fraction [28] .
PI 3-K-dependent activation of Akt/PKB by NA
Recent studies using isolated cells have shown that G-proteincoupled-receptor agonists are able to activate Akt\PKB [23, 24] . However, it is not known whether such activation occurs in intact preparations, and nor are the downstream targets of this kinase in response to vasoconstrictors clear. To investigate whether this pathway may be involved in regulation of DGKθ we first examined Akt\PKB activation in response to NA in intact small arteries. NA rapidly and transiently activated Akt\PKB ( Figure 5 ). The response was maximal at 30 s and returned to basal by 5 min (Figure 5 ). AII induced a slightly slower response, maximal at 60 s (176p18 %, meanpS.E.M., n l 3) but again returning to the baseline at 5 min (results not shown). NAinduced activation of Akt\PKB was prevented completely by the PI 3-K inhibitors wortmannin (0.1 µM) and LY294002 (10 µM; results not shown), demonstrating a role for PI 3-K in this response. 
Figure 6 Wortmannin inhibits NA-induced DGKθ activity but not translocation
PI 3-K inhibition does not prevent NA-induced DGKθ membrane association
Because the time course of Akt\PKB activation in response to NA was similar to the time course of DGKθ translocation to the plasma membrane ( Figures 5 and 3A , respectively) and given that DGKθ possesses PH domains implicated in interactions with 3-phosphoinositides [12, 20] , we examined whether PI 3-K inhibitors would affect NA-induced DGKθ translocation. Pretreatment with wortmannin (0.1 µM) did not prevent the increase in DGKθ membrane association following NA (15 µM) stimulation for 45 s (Figure 6A ), demonstrating that translocation is not dependent on PI 3-K and\or Akt\PKB activity. As with wortmannin, LY294002 (10 µM) did not prevent NA-induced DGKθ membrane association (membrane-associated DGKθ, 100, 129p10 and 154p30 % for control, 15 µM NA, 45 s, and LY294002jNA, respectively ; meanspS.D., n l 2).
PI 3-K inhibition blocks DGKθ activation
Our data ( Figures 3A and 4A) showed that NA-induced membrane association and activation of DGKθ had a close temporal relationship. Therefore to determine whether activation was dependent on a PI 3-K pathway we investigated the effect of wortmannin pretreatment on DGKθ activity. Wortmannin pretreatment had no effect on basal DGKθ activity in immunoprecipitates (DGKθ activity, control, 100 % and 0.1 µM wortmannin, 97p12 %). However, NA (15 µM, 60 s)-stimulated DGKθ activity was completely inhibited by wortmannin (0.1 µM ; Figure 6B ). LY294002 (10 µM) also blocked the NA-induced increase in DGKθ activity in immunoprecipitates (DGKθ activity, 100, 203p35 and 138p35 %, for control, 15 µM NA, 60 s, and LY294002jNA, respectively ; meanspS.E.M., n l 3). Neither wortmannin (0.1 µM) nor LY294002 (10 µM) inhibited DGK kinase activity in lysates from COS cells transfected with cDNA of human DGKθ (results not shown), demonstrating that these compounds had no direct inhibitory effect on DGKθ kinase activity. The differential effects of PI 3-K inhibition on NA-induced DGKθ membrane association (no effect) and activation (marked inhibition) show that activation but not membrane association is dependent on PI 3-K activity. Furthermore, the observation that AII activates Akt\PKB but does not induce membrane association or activation of DGKθ demonstrates that translocation to the plasma membrane is required for subsequent activation.
DGK physically associates with Akt/PKB
To investigate further the role of Akt\PKB in DGK activation we examined whether association occurred between the two kinases by assaying Akt\PKB immunocomplexes for DGK activity. In the absence of stimulation very low DGK activity was detected in Akt\PKB immunoprecipitates (Figure 7) . However, following NA stimulation there was a marked increase ( $ 2 fold) in DGK activity in the immunoprecipitates, demonstrating association of activated DGK with Akt\PKB.
DISCUSSION
We have shown previously that DGK activity is present in soluble and particulate fractions of rat small mesenteric arteries and that the activity in the particulate fraction is increased by NA but not by AII [28] . Here we report that a recently identified DGK isoform, DGKθ [12, 13] , is present in these arteries and that the same vasoconstrictor agonists differentially affect its translocation and activation. To our knowledge, this is the first report describing the translocation and subsequent activation of DGKθ following agonist stimulation. In addition, we show that activation of a PI 3-K pathway is required for DGKθ activation in response to NA.
The finding that DGKθ both associates with the membrane and is activated following stimulation with NA is of physiological relevance since the time of association and maximum activation coincides with peak Ins(1,4,5)P $ production by the same agonist [26] . Furthermore, in a previous study we demonstrated that, at this time point, phosphoinositide-derived DGs are not increased, but that PA is [27] , and the time at which membrane DGKθ levels started to decrease in the present study, phosphoinositidederived DGs have been shown to increase [26] . These data demonstrate a very strong relationship of DGKθ membrane association and activation with phosphoinositide-derived DG metabolism in response to NA. No such translocation and activation of DGKθ was observed following stimulation with AII. Although AII also caused increases in Ins(1,4,5)P $ production, PA levels do not increase, but rather phosphoinositidederived DGs accumulate [27] . Therefore, the differential effects of NA and AII on DGKθ appear to result in the accumulation of different phosphoinositide-derived lipids. The rapid phosphorylation of DG by DGKθ following NA stimulation would lead to an early attenuation of DG levels and presumably PKC activation. On the other hand, AII stimulation results in prolonged elevation of DG levels and therefore more sustained PKC activation. That DGKθ-synthesized PA may have a messenger function by itself cannot be ruled out at present, although this has been argued to be less likely [3, 43] .
Western-blot analysis confirmed that the increased DGKθ activity following NA stimulation was not a consequence of more enzyme being present in the immunoprecipitates. This finding indicates that DGKθ is being activated following NA stimulation. This effect was specific for NA, since AII failed to induce either translocation or activation. Although we immunoprecipitated DGKθ from total homogenates (centrifuged to remove the crude nuclear fraction), the use of the OBG mixedmicelle assay ensured that membrane-associated DGKθ accounted for 70 % of the activity. Taken together, these results show that DGKθ is, at least in part, responsible for the increased DGK activity that was measured in the particulate fraction of small arteries [28] following stimulation of intact vessels with NA.
In resting vessels DGKθ was not only present in the fractions containing the plasma membrane and cytosol but also in that containing the nuclei. Houssa et al. [13] have also detected DGKθ in the membrane and cytosol fractions of COS7 cells transfected with DGKθ cDNA. More recently, by immunofluorescence confocal microscopy they found DGKθ endogenously expressed in the nucleus of these cells (W. J. van Blitterswijk and B. Houssa, unpublished work). DGKα, ζ and ι have also been found in the nucleus (reviewed in [13] ) and the localization of DGKζ has been shown to be regulated by PKC [44] . Since nuclear DG levels have been reported to increase following agonist stimulation (reviewed in [45] ), there might be a role for DGK isoforms (such as DGKθ) in conjunction with PKC in a yet-to-be-defined nuclear signalling event.
In addition to DGKθ being associated with the plasma membrane, our data localizes DGKθ with the Triton-insoluble fraction under basal conditions with a modest increase in association following NA stimulation. The presence of DGKθ in the Triton-insoluble fraction demonstrates its association with membrane rafts (rigid sphingolipid and cholesterol-containing clusters\complexes in membranes), caveolae and\or the membrane cytoskeleton and suggests that DGKθ may interact with lipid signalling complexes [41] . An unidentified DGK(s) was also found to be associated with the detergent-insoluble fraction in A431 cells and its activity was increased upon treatment of intact cells with epidermal growth factor [46] . However, it is not clear whether this increased enzyme activity was due to enhanced DGK binding and\or activation of the enzyme.
Recently, G-protein-coupled receptors have been shown to activate Akt\PKB [23, [47] [48] [49] . In agreement with these studies, NA and AII activated Akt\PKB in intact small arteries, although the time course of the response was far more rapid and shortlived than that observed in AII-stimulated vascular smooth-muscle cells [24] . Both PI 3-K-dependent and -independent mechanisms of Akt\PKB activation have been reported [21] .We were able to completely abolish Akt\PKB-serine%($ phosphorylation with PI 3-K inhibitors, in both agonist-stimulated and -non-stimulated small arteries (results not shown), demonstrating a crucial dependence on PI 3-K activity. Inhibition of PI 3-K and Akt\PKB activity did not affect NA-induced DGKθ membrane association, demonstrating that this pathway is not the signal for translocation. This was confirmed by our observation that AII activates Akt\PKB but not DGKθ membrane association. DG has also been implicated in translocation of DGK activity from the cytosol to the membrane [17, 50] . Although such a mechanism may indirectly influence the association of DGKθ with the plasma membrane following NA stimulation, a direct effect is unlikely since AII also increases the levels of this lipid [26] .
DGKθ activation was dependent on PI 3-K and\or Akt\PKB activity, as shown by the PI 3-K inhibitors wortmannin and LY294002 blocking NA-induced DGKθ activity. These findings demonstrate clearly that membrane association of DGKθ alone is insufficient for activation. Although we detected DGK activity in Akt\PKB immunoprecipitates, which increased significantly following NA stimulation (suggesting a physical interaction between DGK and Akt\PKB), we have been unable to identify the isoform(s) present due to the difficulties of studying specific interactions between endogenous proteins in an intact physiological system. While it is possible that DGKθ activity is regulated by Akt\PKB, alternative PI 3-K-dependent mechanisms could be involved, for instance, in interaction with 3-phosphoinositides or PtdIns-dependant kinase. Clearly, the mechanism by which activation of a PI 3-K pathway regulates DGKθ activity requires further study.
In conclusion, this study together with our previous data [28] strongly suggests that DGKθ attenuates DG signalling and thus presumably PKC activation in NA-stimulated, but not AIIstimulated, small arteries. The differential effect of these two vasoconstrictors, which is seen for both translocation and activation of DGKθ in close temporal relationship, suggests the physiological importance of this DGK isoform in small-artery contraction, specifically that induced by NA.
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